Prevention and treatment strategies for intestinal failure-associated liver disease
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.cn501113-20210811-00393
   		
        
        	
        		- VernacularTitle:肠衰竭相关性肝病的防治策略
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Guochao NIU
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Xiaolan ZHANG
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 河北医科大学第二医院消化内科,石家庄 050035
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Intestinal failure;
			        		
			        		
			        		
				        		Prevention;
			        		
			        		
			        		
				        		Treatment
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Hepatology
	            		
	            		 2022;30(10):1124-1128
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Long-term parenteral nutrition-associated liver dysfunction is caused by intestinal failure and associated complications rather than the parenteral nutrition administration. Intestinal failure-associated liver disease has a diverse etiology, so its prevention and treatment usually require multiple measures at the same time. This article provides a summary of the preventative as well as treatment options for intestinal failure-associated liver disease.